CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content


Last Updated: January 31, 2012
Result type: Reports
Project Number: SR0266-000
Product Line: Reimbursement Review

Generic Name: Prucalopride

Brand Name: Resotran

Manufacturer: Janssen Inc.

Therapeutic Area: Constipation, chronic

Indications: Constipation, chronic

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: July 19, 2012

Recommendation Type: Do not list